Alexander Baker

Alexander Baker has a diverse and extensive work experience in the field of research and development. Alexander is currently working as a Principal Scientist at Accession Therapeutics Limited, where they started in November 2022. Previously, they held the position of Senior Scientist at the same company from January 2022 to November 2022.

Before joining Accession Therapeutics Limited, Alexander worked at Mayo Clinic as a Research Fellow from March 2020 to January 2022. Alexander also served as a Research Collaborator with the Borad lab at Mayo Clinic, where they focused on designing better biological therapies for intractable cancers from June 2019 to March 2020.

In addition to their research roles, Alexander has been involved in various professional organizations. Alexander served as a Board Member for the British Society for Gene and Cell Therapy (BSGCT) starting from October 2021. Previously, they held the position of Co-Chair of the Early Career Development and Collaborations subcommittee at BSGCT, where they promoted the interests of early career researchers in the gene and cell therapy field and facilitated academic and industrial collaborations. Alexander also served as an Early Career Representative at BSGCT from September 2017 to March 2020.

Alexander has also worked as a Research Affiliate at Arizona State University since January 2021 and as an Honorary Research Fellow at Cardiff University School of Medicine since December 2020.

Prior to their academic and research roles, Alexander worked as a Research and Manufacturing Scientist at Absolute Antibody, where they were responsible for the development of novel protein-based reagents. Alexander also gained experience as a British Society for Antimicrobial Chemotherapy Intern at the Marine Biodiscovery Center, where they researched antibiotic production and discovered a new mechanism of antibiotic resistance.

Furthermore, Alexander has demonstrated strong organizational and leadership skills as the Cardiff City Coordinator for Pint of Science, where they successfully organized the first Pint of Science festival in Wales, managing a team of over 35 people.

Overall, Alexander Baker's work experience spans various research and development roles in academia, industry, and professional organizations, showcasing their expertise in the field of gene and cell therapy, protein engineering, and antibiotic research.

Alexander Baker completed their education in a chronological order as follows:

From 2015 to 2019, they pursued a Doctor of Philosophy (PhD) degree in Oncolytic Virology at Cardiff University / Prifysgol Caerdydd.

Prior to that, between 2010 and 2015, Baker obtained their Masters in Science (MSci) degree in Biochemistry from the University of Aberdeen.

Earlier, from 2003 to 2010, they attended Beaumont School, although no specific degree or field of study has been mentioned for this period.

Additionally, Alexander Baker obtained an Associate Fellowship (AFHEA) certification from the Higher Education Academy in June 2020.